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Background:
The control of steroidogenesis in the neonatal adrenal gland is of great clinical interest. We have demonstrated that the newborn rat [postnatal day (PD) 2] exhibits a corticosterone response to hypoxia in the absence of an increase in plasma ACTH measured by radioimmunoassay, whereas the corticosterone response to exogenous ACTH is intact. By PD8, the corticosterone response to hypoxia is ACTH-dependent. This apparently ACTHindependent response to hypoxia in the newborn rat may be due to an increase in a bioactive, non-immunoassayable form of ACTH. Purpose: To evaluate the ACTH-independent response to hypoxia in newborn rats using a novel, specific neutralizing antibody (ALD1611) to ACTH. Methods: Rat pups (N=6-14 per group) were given ALD1611 (20 mg/kg, intraperitoneal) or vehicle on the morning of PD1, PD7, or PD14; 24 hours later (on PD2, PD8, or PD15), baseline blood samples and adrenal glands were obtained. Then, porcine ACTH [1-39] was injected (20 mcg/kg, subcutaneous) or hypoxia (8% O 2 ) was administered, and blood was sampled for ACTH and corticosterone and adrenal glands collected for quantitative polymerase chain reaction (qPCR) 60 minutes later. Results: Treatment with ALD1611 decreased baseline corticosterone and eliminated the corticosterone response to ACTH or hypoxia in all age groups. This occurred despite the fact that hypoxia did not induce a statistically significant increase in plasma ACTH in the PD2 pups. In additional experiments, we found that the magnitude and duration of the attenuation of the adrenal response to ACTH injection or hypoxia was related to the dose of ALD1611 (0.1 mg/kg to 20 mg/kg, intraperitoneal). ALD1611 also blocked stressinduced changes in the expression of mRNAs (by qPCR) of critical adrenal steroidogenic pathway genes. Conclusion: ALD1611 is highly effective in decreasing basal plasma corticosterone and in blocking the adrenocortical response to exogenous ACTH and hypoxic stress in the neonatal rat. We conclude that, despite the minimal increase in plasma ACTH, the adrenal response to hypoxia is ACTH-dependent at all age groups, suggesting stress-induced increases in alternate biologically active forms of ACTH and/or hypoxia-induced increase in adrenal sensitivity in the PD2 neonatal rat. ALD1611 may prove useful in attenuating ACTH-dependent adrenal steroidogenesis in vivo and eventually in treated patients with ACTH-dependent Cushing's syndrome.
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Background: Atrial fibrillation (AF) is the most common arrhythmia and is often associated with cardiomyopathy (CM) and heart failure. There has been little research performed to assess whether there are any differences in patient profile, comorbidities, presenting complaints, and electrocardiographic (ECG) or laboratory characteristics and outcomes between patients who have AF at presentation or preceding the diagnosis of new-onset CM (defined as left ventricular ejection fraction ≤ 40%) and patients who are diagnosed with new-onset CM without any preceding atrial dysrhythmias. Purpose: To assess differences among patients with new-onset CM (LVEF ≤ 40%) with AF and without AF. Methods: We used a balance research design to compare patients diagnosed with new-onset CM with AF (N=196) and without AF (N=197). Demographic characteristics, comorbidities, diagnosis, ECG characteristics, laboratory marker variables, and outcome data were described using appropriate descriptive statistics. The two groups of patients with and without AF were compared using chi-squared and independent t-test. An alpha of 0.05 was used for all statistical tests, and all statistical analysis was done using SAS version 9.4 (SAS Institute Inc., Cary, NC). Results: Patients in the AF-CM group were older (73.51 vs 64.18 years; P<0.001) and more likely to be male (63.3% vs 49.2%; P=0.005), of Caucasian ethnicity (96.9% vs 76.7%; P<0.001), and have a history of hypertension (70.4% vs 53.3%; P=0.0005) or coronary artery disease (33.7% vs 20.8%; P=0.0042). They were more likely to be diagnosed as an outpatient (35.7% vs 10.2%; P<0.0001); if presenting to the hospital, they were much more likely to have congestive heart failure as their presenting complaint (61.1% vs 38.4%; P<0.0001). They also were more likely to have low voltage on their presenting ECG compared to the control group (39% vs 27.6%; P=0.0003). Troponin (0.91 vs 14.27; P=0.0067) and brain natriuretic peptide (771.3 vs 1015.6; P=0.021) values were significantly lower in the AF group. Patients in the AF-CM group showed an increased risk of death: 30.1% vs 20.8% (P=0.0345). Conclusion: Patients with atrial fibrillation and new-onset cardiomyopathy differ from patients without atrial fibrillation in demographic characteristics, comorbidities, venue of diagnosis, presenting complaints, ECG characteristics, laboratory markers, and prognosis. This may have implications for diagnosis, work-up, and treatment of these patients.
Background:
In the United States, 5% of patients incur 50% of health care costs. Hot spotting, a collaborative care approach, may improve patient outcomes and decrease health care costs among those considered to be super-users. Aurora Health Care may benefit from this new and innovative approach to care. Purpose: The purpose of this pilot project was to create a more formalized plan for managing the most complex patients at Aurora St. Luke's Family Practice Center (Milwaukee, WI). Methods: During 2017, 20 medically at-risk patients ≥ 18 years of age were identified and tracked. Each patient was asked to voluntarily participate and verbally consented. Brief patient/family and caregiver surveys were conducted pre-and post-home visit. Following identification of our cohort, an interdisciplinary team meeting was conducted quarterly to discuss patients and to initiate and update care plans. The diverse medical team included a faculty physician, resident(s), clinic social worker, nurse practitioner, clinical pharmacist, registered nurse, and any other available learners. Through these meetings, we attempted to analyze and address each patient's social situation and barriers. There was at least one home visit conducted for each patient and, overall, more frequent contact with the patients and caregivers. Additionally, preand postproject hospital admissions, clinic access, and emergency department (ED) utilization was tracked. Results: Overall, the patient population had a mean age of 62.4 years and was predominately female (70%). The average Charlson score for patients was 6.2 (median: 6). (A score of 6 equates to a 10-year mortality risk of 98%.) Analysis of characteristics of the 20 patients revealed 80% prevalence of mental illness and communication problems; 70% were overmedicated. Comparing the 6-month periods before and after initiating the pilot, total ED visits decreased 20.0% (95 vs 76) and total admissions decreased 35.5% (31 vs 20). Surveys determined that patients, clinic staff, and physicians were very satisfied with the intervention. Overall, 94% of provider respondents felt more patients would benefit from being involved. Conclusion: This well-received collaborative pilot substantially reduced hospital utilization in high-risk clinic patients. We believe this concept has large potential to provide further future benefit and may be replicated elsewhere in the system. In 2018, our pilot efforts will be extended to two residency sites for further evaluation.
